Skip to content

A clinical study of the effects of Jasmine flower extract on raised prolactin levels in women on antipsychotic medicines

Effect of Jasmine flower extract on hyperprolactinemia in female patients on antipsychotic medications

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/08/004829
Enrollment
33
Registered
2014-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Antipsychotic drug-induced hyperprolactinemia

Interventions

Intervention1: Jasmine flower extract nasal drops: Jasmine flower (Jasminum Sambac species) extract: extracted from five hundred grams of jasmine flower added to 375 ml of 90% ethanol and 300 ml de-io

Sponsors

Christian Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult pre-menopausal women; 2. Aged 18 to 45 years; 3. With oligomenorrhea / amenorrhea and / or galactorrhea for at least 3 months duration; 4. Baseline serum prolactin level more than 25 ng/ml; 5. On a stable dose of antipsychotics for the last 3 months; 6. Residing in or around Vellore (within a 70 kilometer radius; 7. Have access to a refrigerator in or near their homes to store study agents.

Exclusion criteria

Exclusion criteria: 1. Not fulfilling inclusion criteria 2. Definite history of sinusitis or asthma

Design outcomes

Primary

MeasureTime frame
Biochemical response: Drop in serum prolactin levels by 25 ng/ml over baseline levelsTimepoint: Baseline Day 7 Day 14 Day 21

Secondary

MeasureTime frame
Adverse eventsTimepoint: During study period (day 1 to day 21);Change in prolactin levels over baseline in biochemical respondersTimepoint: Baseline Day 7 Day 14 Day 21;Clinical response: Reversal of amenorrhea or galactorrheaTimepoint: During study period;Compliance to antipsychoticsTimepoint: Day 7 Day 21;Compliance with study agentsTimepoint: Day 7 Day 21;Mean prolactin levelsTimepoint: Baseline Day 7 Day 14 Day 21;Prolactin changes according to mean dose of antipsychotic drugs (in chlorpromazine equivalents)Timepoint: Baseline Day 7 Day 14 Day 21

Countries

India

Contacts

Public ContactPhilip Finny

Christian Medical College, Vellore

prathap@cmcvellore.ac.in04162284519

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026